Indapamide-Hemihydrate shortage — AU supply status & alternatives

Indapamide-Hemihydrate

—

In shortage · Australia

Tenaxil Sr

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA🇮🇹 IT

Critical shortage

Product discontinued / no longer available on the Australian market.

Reading today’s signals…

✓ Can I substitute?

Yes — under S19A

TGA-approved overseas product

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)

Brand names	Tenaxil Sr

Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

✓

Section 19A approval in force

An alternative brand is available. An overseas-registered product has also been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals

How long have past shortages lasted? from 1 resolved event

◷

~5 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇦🇺

Australia

TGA · just now

Critical

🇨🇦

Canada

HC · just now

Medium

🇮🇹

Italy

AIFA · 7h ago

Medium

Verified timeline regulator events

🇨🇦 27 July 2026

medium reported

🇨🇦 21 July 2026

medium reported

🇦🇺 3 July 2026

medium reported

🇨🇦 3 July 2026

medium reported

🇨🇦 2 July 2026

medium reported

🇮🇹 30 June 2026

medium reported

Sources official regulators

🇨🇦

verified just now

verify ↗

🇦🇺

TGA

verified just now

verify ↗

🇮🇹

AIFA

verified 7h ago

verify ↗

Mederti Drug Report

Generated 1 July 2026 · Australia market · 3 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.